Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3
results
Page 1
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern.
Antiviral Res. 2022 Feb;198:105252. doi: 10.1016/j.antiviral.2022.105252. Epub 2022 Jan 24.
Antiviral Res. 2022.
PMID: 35085683
Free PMC article.
Identification of the First SARS-CoV-2 Lineage B.1.1.529 Virus Detected in Europe.
Vanmechelen B, Logist AS, Wawina-Bokalanga T, Verlinden J, Martí-Carreras J, Geenen C, Slechten B, Cuypers L, André E, Baele G, Maes P.
Vanmechelen B, et al. Among authors: slechten b.
Microbiol Resour Announc. 2022 Feb 17;11(2):e0116121. doi: 10.1128/mra.01161-21. Epub 2022 Feb 3.
Microbiol Resour Announc. 2022.
PMID: 35112910
Free PMC article.
Item in Clipboard
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters.
Abdelnabi R, Foo CS, Zhang X, Lemmens V, Maes P, Slechten B, Raymenants J, André E, Weynand B, Dallmeier K, Neyts J.
Abdelnabi R, et al. Among authors: slechten b.
Antiviral Res. 2022 Feb;198:105253. doi: 10.1016/j.antiviral.2022.105253. Epub 2022 Jan 21.
Antiviral Res. 2022.
PMID: 35066015
Free PMC article.
Item in Clipboard
Cite
Cite